Literature DB >> 29348543

Stroke in 2017: Intensive and extensive - advances in stroke management.

Meng Lee1, Bruce Ovbiagele2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29348543     DOI： 10.1038/nrneurol.2017.187

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Two-Year Outcome after Endovascular Treatment for Acute Ischemic Stroke.

Authors:  Lucie A van den Berg; Marcel G W Dijkgraaf; Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Hester F Lingsma; Charles B L M Majoie; Diederik W J Dippel; Aad van der Lugt; Robert J van Oostenbrugge; Wim H van Zwam; Yvo B W E M Roos
Journal:  N Engl J Med       Date:  2017-04-06       Impact factor: 91.245

2.  Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.

Authors:  Raul G Nogueira; Ashutosh P Jadhav; Diogo C Haussen; Alain Bonafe; Ronald F Budzik; Parita Bhuva; Dileep R Yavagal; Marc Ribo; Christophe Cognard; Ricardo A Hanel; Cathy A Sila; Ameer E Hassan; Monica Millan; Elad I Levy; Peter Mitchell; Michael Chen; Joey D English; Qaisar A Shah; Frank L Silver; Vitor M Pereira; Brijesh P Mehta; Blaise W Baxter; Michael G Abraham; Pedro Cardona; Erol Veznedaroglu; Frank R Hellinger; Lei Feng; Jawad F Kirmani; Demetrius K Lopes; Brian T Jankowitz; Michael R Frankel; Vincent Costalat; Nirav A Vora; Albert J Yoo; Amer M Malik; Anthony J Furlan; Marta Rubiera; Amin Aghaebrahim; Jean-Marc Olivot; Wondwossen G Tekle; Ryan Shields; Todd Graves; Roger J Lewis; Wade S Smith; David S Liebeskind; Jeffrey L Saver; Tudor G Jovin
Journal:  N Engl J Med       Date:  2017-11-11       Impact factor: 91.245

3.  Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.

Authors:  Caterina Breitenstein; Tanja Grewe; Agnes Flöel; Wolfram Ziegler; Luise Springer; Peter Martus; Walter Huber; Klaus Willmes; E Bernd Ringelstein; Karl Georg Haeusler; Stefanie Abel; Ralf Glindemann; Frank Domahs; Frank Regenbrecht; Klaus-Jürgen Schlenck; Marion Thomas; Hellmuth Obrig; Ernst de Langen; Roman Rocker; Franziska Wigbers; Christina Rühmkorf; Indra Hempen; Jonathan List; Annette Baumgaertner
Journal:  Lancet       Date:  2017-03-01       Impact factor: 79.321

4.  Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.

Authors:  Raffaele De Caterina; Giulia Renda; Anthony P Carnicelli; Francesco Nordio; Marco Trevisan; Michele F Mercuri; Christian T Ruff; Elliott M Antman; Eugene Braunwald; Robert P Giugliano
Journal:  J Am Coll Cardiol       Date:  2017-03-21       Impact factor: 24.094

5.  Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.

Authors:  Lars Søndergaard; Scott E Kasner; John F Rhodes; Grethe Andersen; Helle K Iversen; Jens E Nielsen-Kudsk; Magnus Settergren; Christina Sjöstrand; Risto O Roine; David Hildick-Smith; J David Spence; Lars Thomassen
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

6.  Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.

Authors:  Jean-Louis Mas; Geneviève Derumeaux; Benoît Guillon; Evelyne Massardier; Hassan Hosseini; Laura Mechtouff; Caroline Arquizan; Yannick Béjot; Fabrice Vuillier; Olivier Detante; Céline Guidoux; Sandrine Canaple; Claudia Vaduva; Nelly Dequatre-Ponchelle; Igor Sibon; Pierre Garnier; Anna Ferrier; Serge Timsit; Emmanuelle Robinet-Borgomano; Denis Sablot; Jean-Christophe Lacour; Mathieu Zuber; Pascal Favrole; Jean-François Pinel; Marion Apoil; Peggy Reiner; Catherine Lefebvre; Patrice Guérin; Christophe Piot; Roland Rossi; Jean-Luc Dubois-Randé; Jean-Christophe Eicher; Nicolas Meneveau; Jean-René Lusson; Bernard Bertrand; Jean-Marc Schleich; François Godart; Jean-Benoit Thambo; Laurent Leborgne; Patrik Michel; Luc Pierard; Guillaume Turc; Martine Barthelet; Anaïs Charles-Nelson; Christian Weimar; Thierry Moulin; Jean-Michel Juliard; Gilles Chatellier
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

7.  Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Authors:  Jeffrey L Saver; John D Carroll; David E Thaler; Richard W Smalling; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

Review 8.  Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Kuo-Li Pan; Daniel E Singer; Bruce Ovbiagele; Yi-Ling Wu; Mohamed A Ahmed; Meng Lee
Journal:  J Am Heart Assoc       Date:  2017-07-18       Impact factor: 5.501
  8 in total
  1 in total

1.  Development and Validation of Prediction Models for Severe Complications After Acute Ischemic Stroke: A Study Based on the Stroke Registry of Northwestern Germany.

Authors:  Anna K Bonkhoff; Nicole Rübsamen; Christian Grefkes; Natalia S Rost; Klaus Berger; André Karch
Journal:  J Am Heart Assoc       Date:  2022-03-05       Impact factor: 6.106
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.